Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong · Delayed Price · Currency is HKD 43.38
+1.38 (3.29%)
At close: Feb 13, 2026
Sunshine Lake Pharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 482.71 | 1,993 | 76.6 | -587.65 | 839.46 |
Depreciation & Amortization | 395.66 | 391.27 | 377.36 | 259.82 | 122.73 |
Loss (Gain) From Sale of Assets | -10.33 | 0.53 | 0.82 | 19.07 | 5.27 |
Asset Writedown & Restructuring Costs | 86.52 | 485.39 | 288.84 | 25.98 | - |
Loss (Gain) From Sale of Investments | 1.79 | -4.39 | -522.7 | -19.24 | - |
Loss (Gain) on Equity Investments | -0.6 | -0.22 | - | - | - |
Stock-Based Compensation | 89.97 | 45.14 | - | - | - |
Other Operating Activities | -129.95 | 165.31 | 1,084 | 136.21 | -446.26 |
Change in Accounts Receivable | -200.63 | -1,418 | -530.59 | -216.1 | 1,444 |
Change in Inventory | -236.88 | -94.02 | -35.33 | 98.57 | -185.95 |
Change in Accounts Payable | -388.85 | 109.49 | 961.31 | -379.18 | -479.79 |
Operating Cash Flow | 89.42 | 1,673 | 1,700 | -662.51 | 1,299 |
Operating Cash Flow Growth | -94.66% | -1.57% | - | - | -27.58% |
Capital Expenditures | -968.3 | -343.72 | -570.07 | -356.29 | -994.16 |
Sale of Property, Plant & Equipment | 35.76 | - | 0.95 | 0.03 | 19.62 |
Sale (Purchase) of Intangibles | -213.8 | -251.36 | -283 | -223.4 | -923.88 |
Investment in Securities | -9.6 | 2,579 | -290 | - | - |
Other Investing Activities | 1,244 | -1,430 | 21.95 | 140.55 | -196.2 |
Investing Cash Flow | 88.26 | 554.57 | -1,120 | -439.11 | -2,095 |
Long-Term Debt Issued | 1,521 | 2,164 | 517.94 | 444.96 | 518.01 |
Long-Term Debt Repaid | -1,862 | -3,454 | -1,146 | -157.68 | -1.25 |
Total Debt Repaid | -1,862 | -3,454 | -1,146 | -157.68 | -1.25 |
Net Debt Issued (Repaid) | -340.61 | -1,290 | -628.22 | 287.28 | 516.76 |
Repurchase of Common Stock | - | - | - | - | -136.92 |
Common Dividends Paid | - | - | - | - | -219.99 |
Other Financing Activities | -107.7 | -186.63 | -158.8 | -99.8 | -95.22 |
Financing Cash Flow | -448.31 | -1,477 | -787.03 | 187.48 | 64.63 |
Foreign Exchange Rate Adjustments | -0 | -0.01 | -0.3 | 0.29 | -3.67 |
Net Cash Flow | -270.64 | 750.87 | -207.58 | -913.85 | -734.17 |
Free Cash Flow | -878.89 | 1,329 | 1,130 | -1,019 | 305.33 |
Free Cash Flow Growth | - | 17.67% | - | - | -74.93% |
Free Cash Flow Margin | -23.60% | 21.12% | 30.17% | -111.49% | 13.00% |
Free Cash Flow Per Share | -3.79 | 5.73 | 4.87 | -4.39 | 1.05 |
Cash Interest Paid | 93.42 | 138.32 | 112.74 | 99.8 | 95.22 |
Cash Income Tax Paid | 238.82 | 230.49 | 255.43 | -18.62 | 303.73 |
Levered Free Cash Flow | -93.31 | 1,067 | -2,703 | -616.5 | -933.04 |
Unlevered Free Cash Flow | -32.36 | 1,209 | -2,527 | -464.12 | -780.41 |
Change in Working Capital | -826.35 | -1,402 | 395.39 | -496.71 | 778.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.